# XYZAL ALLERGY 24HR
> **NDA209090** · New Drug Application · Sponsor: CHATTEM SANOFI · Approved 2017-01-31
## Drug
- **FDA Application Number:** NDA209090
- **Application type:** New Drug Application
- **Brand name:** XYZAL ALLERGY 24HR
- **Generic name:** LEVOCETIRIZINE DIHYDROCHLORIDE
- **Active ingredients:** LEVOCETIRIZINE DIHYDROCHLORIDE
- **Dosage form:** SOLUTION
- **Route:** ORAL
- **Marketing status:** Over-the-counter
- **Sponsor:** CHATTEM SANOFI
- **Manufacturer:** Chattem, Inc.
- **First approval:** 2017-01-31
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209090)
---
*MORVS · CC0 1.0*